Examples of using Concomitant phase in English and their translations into Slovak
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
Concomitant phase.
Four weeks after completing the TMZ+ RT concomitant phase, TMZ is administered for up to 6 cycles of monotherapy treatment.
Temodal dose may be delayed or stopped,depending on you blood counts and how you tolerate your medicine during the concomitant phase.
During the concomitant phase, your doctor will start Temodal at a dose of 75 mg/m2(usual dose).
The Temozolomide SUN dose may be delayed or stopped,depending on your blood counts and how you tolerate your medicine during the concomitant phase.
During the concomitant phase, your doctor will start Temozolomide Hexal at a dose of 75 mg/m2(usual dose).
The Temozolomide Hexal dose may be delayed or stopped,depending on your blood counts and how you tolerate your medicine during the concomitant phase.
Four weeks after completing the TMZ+ RT concomitant phase, TMZ is administered for up to 6 cycles of monotherapy treatment.
TMZ administration should be temporarily interrupted orpermanently discontinued during the concomitant phase according to the haematological and non-haematological toxicity criteria as noted in Table 1.
Treatment together with radiotherapy(concomitant phase) first followed by treatment with only Temodal(monotherapy phase). .
Four weeks after completing the TMZ+ RT concomitant phase, TMZ is administered for up to 6 cycles of monotherapy treatment.
Temodal is first used together with radiotherapy(concomitant phase of treatment) and after that alone(monotherapy phase of treatment).
Temodal is first used together with radiotherapy(concomitant phase of treatment) and after that alone(monotherapy phase of treatment).
Temodal is administered in combination with focal radiotherapy(concomitant phase) followed by up to 6 cycles of temozolomide(TMZ) monotherapy(monotherapy phase). .
Temozolomide dosing should be interrupted or discontinued during concomitant phase according to the hematological and nonhematological toxicity criteria as noted in Table 1.